ID: ALA4799864

Max Phase: Preclinical

Molecular Formula: C33H29N7O4

Molecular Weight: 587.64

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCOc1nc2cccc(C(=O)NCCc3ccc4c(c3)OCO4)c2n1Cc1ccc(-c2ccccc2-c2nnn[nH]2)cc1

Standard InChI:  InChI=1S/C33H29N7O4/c1-2-42-33-35-27-9-5-8-26(32(41)34-17-16-21-12-15-28-29(18-21)44-20-43-28)30(27)40(33)19-22-10-13-23(14-11-22)24-6-3-4-7-25(24)31-36-38-39-37-31/h3-15,18H,2,16-17,19-20H2,1H3,(H,34,41)(H,36,37,38,39)

Standard InChI Key:  ORXHWEANNIVLGT-UHFFFAOYSA-N

Associated Targets(Human)

NEDD8-activating enzyme E1 regulatory subunit 121 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

A549 127892 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 587.64Molecular Weight (Monoisotopic): 587.2281AlogP: 5.03#Rotatable Bonds: 10
Polar Surface Area: 129.07Molecular Species: ACIDHBA: 9HBD: 2
#RO5 Violations: 2HBA (Lipinski): 11HBD (Lipinski): 2#RO5 Violations (Lipinski): 3
CX Acidic pKa: 4.23CX Basic pKa: 1.91CX LogP: 5.73CX LogD: 4.13
Aromatic Rings: 6Heavy Atoms: 44QED Weighted: 0.23Np Likeness Score: -1.04

References

1. Chen X,Yang X,Mao F,Wei J,Xu Y,Li B,Zhu J,Ni S,Jia L,Li J.  (2021)  Development of novel benzimidazole-derived neddylation inhibitors for suppressing tumor growth invitro and invivo.,  210  [PMID:33129593] [10.1016/j.ejmech.2020.112964]

Source